These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33336185)

  • 1. VANGUARD®crLyme: A next generation Lyme disease vaccine that prevents
    Marconi RT; Garcia-Tapia D; Hoevers J; Honsberger N; King VL; Ritter D; Schwahn DJ; Swearingin L; Weber A; Winkler MTC; Millership J
    Vaccine X; 2020 Dec; 6():100079. PubMed ID: 33336185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single immunization of
    Chambers GZ; Chambers KMF; Marconi RT
    Infect Immun; 2024 Nov; 92(11):e0039624. PubMed ID: 39436053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
    Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
    BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of novel multi-protein chimeric immunogens that protect against infection with the Lyme disease agent,
    O'Bier NS; Camire AC; Patel DT; Billingsley JS; Hodges KR; Marconi RT
    mBio; 2024 Oct; 15(10):e0215924. PubMed ID: 39287439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of antibody responses to outer surface protein (Osp)A and OspC in dogs vaccinated with Lyme disease vaccines.
    Camire AC; Hatke AL; King VL; Millership J; Ritter DM; Sobell N; Weber A; Marconi RT
    Vet J; 2021 Jul; 273():105676. PubMed ID: 34148599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated immunological memory correlates with long-term Lyme veterinary vaccine protection in mice.
    Gutierrez MP; Huckaby AB; Yang E; Weaver KL; Hall JM; Hudson M; Dublin SR; Sen-Kilic E; Rocuskie-Marker CM; Miller SJ; Pritchett CL; Mummadisetti MP; Zhang Y; Driscoll T; Barbier M
    Vaccine; 2024 Oct; 42(24):126084. PubMed ID: 38937181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
    Izac JR; Oliver LD; Earnhart CG; Marconi RT
    Vaccine; 2017 May; 35(24):3178-3185. PubMed ID: 28479174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Elucidation of a Protective B Cell Epitope on Outer Surface Protein C (OspC) of the Lyme Disease Spirochete, Borreliella burgdorferi.
    Rudolph MJ; Davis SA; Haque HME; Weis DD; Vance DJ; Piazza CL; Ejemel M; Cavacini L; Wang Y; Mbow ML; Gilmore RD; Mantis NJ
    mBio; 2023 Apr; 14(2):e0298122. PubMed ID: 36976016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and optimization of OspC chimeritope vaccinogens for Lyme disease.
    Izac JR; O'Bier NS; Oliver LD; Camire AC; Earnhart CG; LeBlanc Rhodes DV; Young BF; Parnham SR; Davies C; Marconi RT
    Vaccine; 2020 Feb; 38(8):1915-1924. PubMed ID: 31959423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice.
    Schwan TG; Piesman J
    J Clin Microbiol; 2000 Jan; 38(1):382-8. PubMed ID: 10618120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field safety study of VANGUARD®crLyme: A vaccine for the prevention of Lyme disease in dogs.
    Marconi RT; Honsberger N; Teresa Winkler M; Sobell N; King VL; Wappel S; Hoevers J; Xu Z; Millership J
    Vaccine X; 2020 Dec; 6():100080. PubMed ID: 33336186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Borrelia burgdorferi ospC genotypes in canine tissue following tick infestation: implications for Lyme disease vaccine and diagnostic assay design.
    Rhodes DV; Earnhart CG; Mather TN; Meeus PF; Marconi RT
    Vet J; 2013 Nov; 198(2):412-8. PubMed ID: 23962611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of the ability of a canine Lyme vaccine to reduce the incidence of histological synovial lesions following experimentally-induced canine Lyme borreliosis.
    Grosenbaugh DA; Rissi DR; Krimer PM
    Vet Immunol Immunopathol; 2016 Nov; 180():29-33. PubMed ID: 27692092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.
    LaFleur RL; Dant JC; Wasmoen TL; Callister SM; Jobe DA; Lovrich SD; Warner TF; Abdelmagid O; Schell RF
    Clin Vaccine Immunol; 2009 Feb; 16(2):253-9. PubMed ID: 19052162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tick-Tattoo: DNA Vaccination Against
    Klouwens MJ; Trentelman JJA; Wagemakers A; Ersoz JI; Bins AD; Hovius JW
    Front Immunol; 2021; 12():615011. PubMed ID: 33717102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of horses with Lyme vaccines for dogs induces short-lasting antibody responses.
    Guarino C; Asbie S; Rohde J; Glaser A; Wagner B
    Vaccine; 2017 Jul; 35(33):4140-4147. PubMed ID: 28668566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a nonadjuvanted, outer surface protein A, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia burgdorferi.
    Conlon JA; Mather TN; Tanner P; Gallo G; Jacobson RH
    Vet Ther; 2000; 1(2):96-107. PubMed ID: 19757556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA.
    Eschner AK; Mugnai K
    Parasit Vectors; 2015 Feb; 8():92. PubMed ID: 25890386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses.
    Izac JR; Camire AC; Earnhart CG; Embers ME; Funk RA; Breitschwerdt EB; Marconi RT
    Vaccine; 2019 Apr; 37(17):2401-2407. PubMed ID: 30922701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus ticks removed from humans.
    Fingerle V; Liegl G; Munderloh U; Wilske B
    Med Microbiol Immunol; 1998 Oct; 187(2):121-6. PubMed ID: 9832327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.